But despite the recent dip, many analysts believe CSL shares are undervalued and present a solid long-term investment opportunity. Let's see what the experts say. Several factors have weighed on ...

It said: CSL is one of the world's largest global plasma fractionators. The plasma products themselves have proven excellent medical products, with wide application, and deliver therapeutic ...

CSL (AU:CSL) has released an update. CSL Limited is hosting its 2024 Research & Development Investor Briefing, offering investors insights into the company’s latest innovations and strategic ...

CSL became one of Australia’s biggest companies from the fast-growing immunoglobulin products derived from blood at the heart of its portfolio. Dr Mezzanotte said plasma products would remain ...

(RTTNews) - At the Annual General Meeting, Paul McKenzie, Chief Executive Officer of CSL Ltd. (CSL.AX), reaffirmed the company's financial guidance for fiscal year 2025. The company still expects ...

Shares of building envelope solutions provider Carlisle Companies (NYSE:CSL) fell 8.4% in the morning session after the company reported disappointing third-quarter earnings results. Its revenue ...

Building envelope solutions provider Carlisle Companies (NYSE:CSL) fell short of the market’s revenue expectations in Q3 CY2024, but sales rose 5.9% year on year to $1.33 billion. Its non-GAAP ...

Plasma donation centers, such as the new BioLife Plasma Services, are bringing in donors and re-igniting ethical questions.

Christmas is always an important time for The Salvation Army, as it meets the needs of the community while depending on the ...

The $1.25 million CSL Centenary Fellowship has enabled Dr Weeden to return from the Crick Institute in London to establish her own research laboratory at WEHI in Melbourne. She plans to identify how ...